𝗙𝗜𝗥𝗦𝗧 𝗔𝗟𝗭𝗛𝗘𝗜𝗠𝗘𝗥’𝗦 𝗕𝗟𝗢𝗢𝗗 𝗧𝗘𝗦𝗧:...

Discover how the first FDA-cleared blood test for Alzheimer’s disease, developed by Fujirebio,...

Overview of Alzheimer’s disease...

hello guys today's topic is ALZHEIMER"S DISEASE source
HomeAnxiety disorderEmmy-Nominated Actor Christina...

Emmy-Nominated Actor Christina Applegate Shares Multiple Sclerosis Struggles


Can early diagnosis, disease-modifying therapy and healthy lifestyle help slow multiple sclerosis progression and disability?

Actor Christina Applegate has revealed that she now spends much of her time in bed due to the worsening impact of multiple sclerosis (MS), offering a candid account of life with the chronic neurological disease ahead of the release of her memoir.

The 54-year-old, who was diagnosed with MS in 2021, said pain triggered by even minor movement has significantly reduced her mobility, leaving her largely bedridden on many days. Despite the physical limitations, she continues to prioritize taking her teenage daughter to school, describing it as the most meaningful part of her daily routine.

Applegate said her condition has reshaped her daily life, with basic activities requiring careful planning and recovery time. Her bedroom has effectively become a sanctuary where she manages symptoms and conserves energy.

Living With A Progressive Neurological Disease

Multiple sclerosis () is an autoimmune condition in which the immune system attacks the protective myelin sheath around nerve fibers, disrupting communication between the brain and the rest of the body.

Globally, MS affects more than 2.8 million people and is a leading cause of non-traumatic neurological disability in young adults. The disease carries significant physical, emotional and economic burdens, often requiring long-term rehabilitation, assistive devices and caregiver support. The disease often causes pain, fatigue, balance problems and difficulty walking, and in some cases can lead to partial paralysis.

Symptoms vary widely and can fluctuate from day to day, making it difficult for patients to predict mobility and energy levels. There is currently no cure, though treatments can help manage relapses and slow progression.

Balancing Illness And Family Life

Applegate has spoken openly about the emotional toll of MS on her family, particularly her daughter, noting that she can no longer do many of the activities she once enjoyed. Still, she makes an effort to maintain small routines that provide a sense of normalcy.

Her memoir, You With the Sad Eyes, reflects on her health challenges alongside earlier experiences including breast cancer, childhood trauma and the pressures of early fame. She has described the book as a raw and honest account rather than a conventional inspirational narrative.

No Cure, But Treatments Can Slow Progression

There is currently no cure for multiple sclerosis, but disease-modifying therapies (DMTs) can reduce relapse rates and slow disease progression by targeting immune activity. Additional treatments focus on symptom management, including medications for spasticity, neuropathic pain and fatigue, as well as physiotherapy and mobility aids.

Early diagnosis and sustained treatment are critical in delaying disability, though response to therapy varies widely. Health experts say increased awareness, timely access to specialist care and continued research into neuroprotective therapies are essential to improve outcomes and quality of life for people living with MS.

By sharing her experience publicly, Applegate has drawn attention to the realities of living with a chronic, invisible illness and the need for greater awareness, accessibility and support for people with multiple sclerosis.



References:

  1. Multiple Sclerosis (MS): What It Is, Symptoms & Treatment – (https://my.clevelandclinic.org/health/diseases/17248-multiple-sclerosis)

Source-Medindia

Continue reading

Genetic Mismatch Triples Severe Immune Risk

Cord blood transplants are known to tolerate genetic mismatches better than other donor sources. But one specific HLA pairing may sharply raise the risk of severe...

𝗙𝗜𝗥𝗦𝗧 𝗔𝗟𝗭𝗛𝗘𝗜𝗠𝗘𝗥’𝗦 𝗕𝗟𝗢𝗢𝗗 𝗧𝗘𝗦𝗧: 𝗚𝗔𝗠𝗘-𝗖𝗛𝗔𝗡𝗚𝗘𝗥 𝗜𝗡 𝗘𝗔𝗥𝗟𝗬 𝗗𝗜𝗔𝗚𝗡𝗢𝗦𝗜𝗦

Discover how the first FDA-cleared blood test for Alzheimer’s disease, developed by Fujirebio, is transforming early detection and diagnosis. This breakthrough not only simplifies screening but also brings huge economic and clinical value—especially amid shrinking federal funding for Alzheimer’s...

Can Organ Donation Happen After the Heart Stops?

Donation after circulatory death now accounts for nearly half of all deceased organ donors in the United States. Advances in preservation technology are helping make more...